To determine whether mean leukocyte telomere length (LTL) serves as a biomarker of disability assessed according to activities of daily living (ADLs) and what factors may modify this relationship. DESIGN: Retrospective cross-sectional study. SETTING: A subset of the National Long Term Care Survey (NTLCS), a Medicare-based U.S. population longitudinal study focused on trends of overall health and functional status in older adults. PARTICIPANTS: Six hundred and twenty-four individuals from the 1999 wave of the NTLCS cohort. MEASUREMENTS: Relative LTL determined according to quantitative polymerase chain reaction. LTL has previously been shown to correlate with common age-related disorders and mortality, as well as with socioeconomic status. RESULTS: A sex difference in LTL was observed but not age-dependent shortening or association with socioeconomic status. LTL was associated with disability and functional status assessed according to ADLs. The association between ADLs and LTL was stronger in subjects without diabetes mellitus, whereas associations were not seen when only subjects with diabetes mellitus were analyzed. Associations between LTL and cardiovascular disease (CVD) and cancer were also present in the group without diabetes mellitus but not in the group with diabetes mellitus. CONCLUSION: These findings support the concept that LTL is a biomarker of overall well-being that is predictive of disability of older individuals in the U.S. population. Diabetes mellitus plays an important role as a modifier of the association between LTL and disability, CVD, and cancer. These associations have clinical implications because of the potential predictive value of LTL and deserve further investigation.
T elomeres are the TTAGGG repeat sequences at the ends of chromosomes that prevent their end-to-end fusion. They become progressively shorter at each cell division because of the end replication problem. 1 Telomere shortening occurs in vivo during human aging, with genetic, epigenetic, and environmental factors determining the rates of the shortening. 2, 3 Oxidative damage is thought to be the major environmental factor that accelerates telomere shortening in vitro 4 as well as in vivo. 5 Recently, leukocyte telomere length (LTL) has been the subject of intense study to examine relationships with the physiological and pathological changes associated with aging of human populations. 6 Correlations have been observed between LTL and common age-related disorders, including atherosclerosis, 7 myocardial infarction, 8, 9 chronic heart failure, 10 vascular dementia, 11 Alzheimer's disease, 12 osteoporosis, 13 cancer, 14, 15 diabetes mellitus type 2, 9, 16, 17 and insulin resistance. 5, 9, 18, 19 Shorter telomeres have also been shown to correlate with high levels of inflammation. 9, 19 Oxidative damage and low antioxidative capacity have been postulated as one of the underlying causes of accelerated telomere shortening that leads to the greater incidences of these disorders. 4, 5 Telomere shortening has also been observed in some premature aging syndromes, such as dyskeratosis congenita 20 and aplastic anemia, 21 supporting the notion that accelerated telomere attrition with age predisposes to disease.
Some of the most important risk factors for agingrelated diseases, such as smoking, obesity, and lack of physical activity, appear to shorten telomeres. 18, 22 In addition, low socioeconomic status has also been related to shorter telomeres independent of the effects of smoking, obesity, and lack of exercise, 23 although the relationship between social status and LTL is controversial, with another study failing to find this association. 24 Life stress, both self-assessed and objectively scored, correlates with higher oxidative stress, determined according to F2-isoprostanes, and shorter telomeres. 25 These findings are consistent with a number of studies that have linked chronic stress and poor health to shorter telomeres and point to LTL as an overall indicator of well being. 26 Moreover, shorter leukocyte telomeres have also been associated with mortality in persons aged 60 and older 27 that is attributed to heart disease and infectious diseases, although these results were not reproduced in subsequent studies, arguably because they were performed in older populations. [28] [29] [30] Recently, a retrospective study of elderly twins demonstrated that LTL predicts mortality, suggesting that it might be not only a bioindicator of aging, but also a determinant of life span. 31 In addition, LTL has been associated with mortality in specific groups of patients, such as stroke survivors, 11 patients with Alzheimer's disease, 12 and patients with stable coronary artery disease. 32 The fact that women live longer than men and also have significantly longer telomeres 33 suggests a relationship between longevity and telomere length, but as indicated above, there are many additional factors likely to drive this relationship.
This study aimed to explore the role of LTL as a biomarker of successful aging by analyzing its relationship with measurements of disability (overall health and functional status) collected in the National Long Term Care Survey (NLTCS). The NLTCS is a cross-sectional and longitudinal study representative of U.S. Medicare recipients, and it is considered to be one the best-designed surveys to assess chronic ( !90 days) disability. [34] [35] [36] The current study examined whether LTL predicts disability indicated by activities of daily living (ADLs) and instrumental activities of daily living (IADLs) and, if so, what factors may modify this relationship. To the authors' knowledge, this is the first study to demonstrate the correlation between disability and LTL.
METHODS

Study Population
The NLTCS is a nationally representative survey that provides a large set of self-and proxy-reported data on health and functioning of older U.S. adults (!65) over 18 years. It had five waves (1982, 1984, 1989, 1994, and 1999 ; data from the sixth wave completed in 2004/05 were not available for this study), each linked to Medicare service use and vital statistics files. The NLTCS is considered to be one of the best designed surveys to assess chronic (!90 days) disability. 34 A two-stage-selection interviewing process was used. First, a screening interview assessing chronic disability (activity limitations due to disability or health problems that require active help, standby help, or equipment use and last !90 days) was given to all participants randomly selected from the Medicare enrollees. Second, a detailed interview was administered to those who reported at least one chronic ADL or IADL disability (see below), institutionalized individuals, and those who received a detailed interview in a previous survey. The details of this protocol have been described previously (for further details, see 34, 37, 38 ). The 1994 and 1999 surveys also explicitly included samples of individuals who were designated for detailed interviews even if initially ''screened out'' as noninstitutional and unimpaired during the screening interview (healthy supplements). Thus, according to the survey design, disabled persons were oversampled in detailed questionnaires, which provided a unique opportunity to focus on this vulnerable portion of the older population.
Disability Measures
The NLTCS assesses chronic disability at two levels: moreserious disabilities, which include ADL (eating, getting in and out of bed, getting around inside, getting to the bathroom and using the toilet, dressing, and bathing) limitations, 39 and less-serious disabilities associated with IADL (doing heavy work, doing light work, doing laundry, cooking, shopping for groceries, getting around outside, going places outside of walking distance, managing money, making telephone calls, and taking medicines) limitations. 40 Thus, any disability (in ADLs and IADLs) was considered an ADL disability. Because ADL disabilities reflect moreserious disabilities, by choosing these two groups disabilities with distinct severity levels were covered. ). Smoking indicates smoking status at the time of the 1999 NLTCS interview. Information on occurrence of infectious disease, cardiovascular disease (CVD), and diabetes mellitus was obtained from the Medicare service use files linked to the NLTCS data. The Medicare claims data records are classified according to type of services (Part A benefits covering inpatient care in short-and long-stay hospitals, skilled nursing facilities, home health, and hospice care; Part B benefits covering physician services, outpatient care, durable medical equipment, and home health agency in some cases) and contain information on dates and costs of services, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnoses responsible for the services, and auxiliary diagnostic codes and procedure codes. Information from Part A and Part B claims for the available time period (since January 1, 1991) were used to define occurrence of the diseases during that time interval based on the respective ICD-9-CM codes and dates of claims. If an individual had any Medicare claim (Part A or Part B) with a date of service earlier than the date of blood draw and associated with respective ICD-9-CM codes (001-139 for infectious diseases; 401-405, 410-414, 428-429, and 440-442 for CVD; and 250 and 357.2 for diabetes mellitus; all 4-and 5-digit codes within the respective codes were used), the disease status was set as ''prevalent'' for that individual. Because the claims data are available since January 1, 1991, ''prevalent'' reflects the occurrence of respective disease since that time until the date of the blood draw ($ 10 years) and may not correspond to the history of the disease during the entire life span in the case of nonchronic diseases. Lung diseases (pneumonia, bronchitis, emphysema, and asthma), musculoskeletal diseases (rheumatism, arthritis, broken hip or other broken bone), and cancer are based on the NLCTS interview.
Genomic deoxyribonucleic acid (DNA) was isolated using QIAamp blood isolation kits and the Qiagen BioRobot2000 system (Qiagen, Inc., Valencia, CA) according to the manufacturer's instructions. Genomic DNA samples were kept in 96-well microtiter plates in duplicates and stored at À 801C. Fourteen cases had insufficient DNA available for telomere length measurements; thus, the final number of cases included in this study was 624. Apolipoprotein E (ApoE) genotyping had been previously performed on the same DNA samples. 37, 38 The institutional review board of the University of Washington approved this study.
Telomere Quantitative Polymerase Chain Reaction LTL was measured according to quantitative polymerase chain reaction (qPCR), as previously described. 15, 41 For each sample, two PCR reactions were performed: one to amplify the telomeric DNA and the other to amplify a single-copy control gene (36B4, acidic ribosomal phosphoprotein PO). The latter serves as an internal standard to normalize the starting amount of DNA. A four-point standard curve using 10, 5, 2.5, and 1.25 ng of control DNA was used to transform cycle threshold into nanograms of DNA. All reactions were run in triplicate, and the median result was used for subsequent calculations. A relative measurement of the telomere lengths, T/S ratio, was calculated as the amount of telomeric DNA (T) divided by the amount of single-copy internal control gene DNA (S). Two control DNA samples were included in each run to allow for normalization between experiments, and periodic reproducibility experiments were performed to guarantee accurate measurements. The intra-and interassay variability (coefficient of variation) for qPCR were 6% and 7%, respectively.
Statistical Analysis
Because the distribution of LTL as measured according to T/ S ratio was confirmed to be normal, comparison of means between groups was performed using a nonpairwise twosided t test, and P-values were adjusted for multiple comparisons. Logistic regression was used to evaluate the odd ratios (ORs) and 95% confidence intervals (95% CIs) of LTL, using two indicator variables that compare lower tertile with upper tertile (referent category) and middle tertile with upper tertile of the LTL distribution, for risk of any disability or ADL disability. Three types of models with different adjustments on covariates were estimated: unadjusted; adjusted for age and sex; adjusted for age, sex, race, BMI, ApoE e4, smoking status, and education. All analyses were performed using the MATLAB Statistics Toolbox (Natick, MA).
RESULTS
The cohort used for this study included a subset of 624 participants from the 1999 wave of NLTCS that provided blood samples. The characteristics of the cohort are summarized in Table 1 . It consisted of 43.9% men and 56.1% women. There were no significant differences in age distribution, race, or education between men and women. Disability appeared more prevalent in women but did not reach statistical significance (P 5.05). Men had a significantly higher frequency of smoking (P 5.009) and a higher BMI (Po.001). The frequencies of ApoE genotypes were not different between men and women. 37, 38 The average age of the individuals in this study was 74 (range 65-88). The average LTL, determined according to qPCR, was 0.66 AE 0.13 (range 0.31-1.05), expressed on the T/S scale. LTL was not significantly associated with age in a simple linear regression (coefficient of determination (R 2 ) 5 0.0009, P 5.45), or when the linear regression model was adjusted for sex, BMI, smoking, and diabetes mellitus (R 2 5 0.012, P 5.80). Nor was age-dependent telomere shortening observed in specific groups of individuals based on demographic and clinical variables (data not shown).
LTL of women was significantly longer than that of men (P 5.01) ( Table 2 and Figure 1A ). There was no significant association between telomere length and age (P 5.47), race (P 5.32), smoking (P 5.45), BMI (P 5.99), and ApoE genotype (P 5.50) in this sample population (Table 2 ). There was a trend toward and association between education levels higher than high school graduate and longer telomeres, but it was not significant (P 5.11).
Information on functional status assessed according to ADLs and IADLs was available in 621 individuals ( Table 1) . The association between telomere length and functional status categorized into six groups (nondisabled; disabled in IADLs; disabled in 1 or 2 ADLs, 3 or 4 ADL, 5 or 6 ADLs; institutionalized) was not significant (P 5.12; Table 2 ), although when individuals with any disability (IADL and any ADL) were grouped together and compared with nondisabled individuals, the former had shorter telomeres (P 5.07, Table 2 and Figure 1B) . Moreover, the individuals who had disabilities in ADLs had significantly shorter telomeres than those who did not have any serious disabilities (that is, nondisabled or disabled only for IADLs) (P 5.03, Table 2 and Figure 1C) .
Next, the correlation between common age-related disorders and LTL in this population was assessed. The common disorders examined were infectious disease, CVD, cancer, diabetes mellitus, lung disease, and musculoskeletal disease (Table 3) . After adjusting for multiple comparisons, a significantly shorter telomere length was observed in patients with cancer than in those who were cancer-free (P 5.048, Table 3 and Figure 1E ). Significantly longer telomeres were also observed in patients with CVD than in those without (P 5.048, Table 3 and Figure 1F ). There was no significant association between any of the other diseases and LTL after adjusting for multiple comparisons. Linear regression models controlling for age and sex were also calculated. The observed associations between LTL and the diseases were similar to that presented in Table 3 . Respective regression parameters for the diseases (coded as 1 5 prevalent, 0 5 not prevalent) were À 0.051 for cancer (95% CI 5 À 0.094 to À 0.008), 0.015 (95% CI 5 À 0.011-0.041) for lung disease, À 0.025 (95% CI 5 À 0.047 to À 0.002) for musculoskeletal disease, 0.016 (95% CI 5 À 0.006-0.037) for infectious disease, 0.03 (95% CI 5 0.004, 0.057) for CVD, and 0.01 (95% CI 5 À 0.013, 0.032) for diabetes mellitus. So individuals with cancer still tend to have shorter LTL, whereas those with CVD tend to have longer LTL, after controlling for age and sex. Addition of cancer as a covariate (for diseases other than cancer) did not substantially change the estimates (data not shown).
Given the high level of interaction between different age-related factors, it is conceivable that the associations between telomere length and disability and aging might be evident only for subsets of individuals with or without certain demographic or clinical parameters. To test this hypothesis, the population was stratified according to the categories defined by all the variables of study, and possible associations between LTL and disability and age-related diseases were investigated in each of the subgroups. Striking differences were found in the LTL associations between people with and without diabetes mellitus that were not observed after stratifying according to other aging diseases (data not shown). In patients with diabetes mellitus, the associations between LTL and sex and disability were not significant, although in patients without diabetes mellitus, they were significant and even more pronounced than in the whole population ( Figure 1A-C) . Moreover, an intriguing opposite association between telomere length and ApoE e4 was found depending on diabetes mellitus ( Figure 1D ). Although the e4 allele was associated with significantly shorter telomeres in patients with diabetes mellitus (P 5.04), it was related to significantly longer telomeres in individuals without (P 5.04). The inverse correlation between telomere length and cancer was also significant for patients without diabetes mellitus (P 5.01, Figure 1E ), but was lost in those with diabetes mellitus. In addition, the association between CVD and telomere length was positive for patients without diabetes mellitus (P 5.005) but negative for those with (P 5.05, Figure 1F ). Last, logistic regression models were used to determine the risk of disability due to shorter telomeres and to explore whether this risk was still significant after adjusting for variables known to be related to telomere length. Shorter telomeres were significantly associated with higher risk of ADL disability in the unadjusted model and after adjusting for age and gender or for age, gender, race, BMI, ApoE e4, smoking, and education (Table 4 ). The highest OR (for lower vs upper tertiles of the LTL distribution) corresponded to the model adjusted for age, sex, race, BMI, ApoE e4, smoking, and education (OR 5 1.82, 95% CI 5 1.14-2.92). For the risk of any disability, the model with multiple adjustments also showed a significantly greater risk associated with shorter telomeres. Individuals with telomeres in the lower tertile had 1.57 (95% CI 5 1.02-2.43) times the risk of any disability (ADL or IADL) than individuals with telomeres in the reference upper tertile category, independent of age, sex, race, BMI, ApoE e4, smoking, or education. None of the models showed significant difference between the lower and middle tertiles of the LTL distribution. When stratifying according to diabetes mellitus, an even higher risk of ADL disability associated with shorter telomeres was observed. Subjects without diabetes mellitus with telomeres in the lower tertile had 2.94 (95% CI 5 1.52-5.72) times the risk of ADL disability as individuals with telomeres in the upper tertile, after multiple adjustments. The risk for any disability in people without diabetes mellitus was smaller (OR 5 1.64) and nonsignificant. The same effects were observed when quartiles of telomere length were used for the same analysis of risk, the only difference being slightly higher ORs and larger P-values, due to smaller number of individuals in each group (data not shown).
DISCUSSION
This study demonstrated that LTL is associated with disability of older individuals in the U.S. population. Although many studies have shown that LTL is related to diseases and risk factors of aging, to the authors' knowledge, this is the first study that reports a comprehensive analysis of the potential of LTL to predict disability. This has been possible thanks to the NLTCS, a valuable resource for aging studies, because it was specifically designed to assess health and functioning in older adults. By classifying disability into ADLs and IADLs, it was possible to demonstrate that individuals with shorter telomeres were more likely to have disabilities, especially severe disabilities, than those with longer telomeres. These included disabilities in any of the following ADLs: eating, getting in and out of bed, getting around inside, getting to the bathroom and using the toilet, dressing, and bathing. Although these disabilities might be the consequence of diseases of aging, their quantification as ADL or IADL disabilities constitutes a better cumulative index of physical and cognitive health and well-being than a specific list of age-related diseases. Aging is defined as the progressive loss of biological functions, and thus, it is highly relevant that a comprehensive measurement of major biological disabilities correlates with LTL. 42 The results of the current study are in agreement with a recent study that reported a positive association between LTL and years of healthy life. An interesting aspect of the results is the modulating effect of diabetes mellitus on the associations between telomere length and disability. Shorter telomeres were related to disability only in subjects without diabetes mellitus. Diabetes mellitus seemed to modify not only the association between telomere length and disability, but also the association with sex, cancer, CVD, and ApoE e4. ApoE e4 had opposite effects on telomere length depending on disease status; in patients with diabetes mellitus, the presence of the e4 allele was associated with shorter telomeres, whereas in those without, it was associated with longer telomeres. ApoE plays an important role in the transport of cholesterol and other lipids, and it has been associated with CVD, Alzheimer's disease, and longevity. 43 It has recently been demonstrated that ApoE polymorphisms are also related to disability, but these relationships are not simple and involve differences in genotype, sex, and severity of disability. 37 Thus, the complex relationships that exist between all these factors 44 might explain the modifying effect of diabetes mellitus observed here and the discrepancies between studies. For instance, although diabetes has been associated with shorter telomeres in some studies, 9, 16, 17 that was not the case in this study and others. 8, 10 Nevertheless, because these analyses were performed before diabetes mellitus was tested as a modifier, there is a need to replicate these results to confirm these findings.
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Regarding associations with diseases of aging, it was found that shorter telomeres are related to cancer, in agreement with previous studies, 14, 15 although positive correlation was found between longer telomeres and CVD, which was opposite from expectations. This association is reversed in the case of patients with diabetes mellitus, in which CVD is associated with shorter telomeres, as has previously been reported in the literature, [8] [9] [10] although only six participants had diabetes mellitus and no CVD. One possible explanation as to why those who have CVD had longer LTL in this study is that people with CVD with short telomeres might have died earlier, which could skew the remaining participants toward people with CVD with longer telomeres. A second explanation for these unexpected results might be in part due to the bias of the physicians who made the diagnosis for Medicare, because the Medicare records lack standardization. 45 The potential bias includes the underdiagnosis of the disorders due to the lack of Medicare claims data for people younger than 65 and for years before 1991. A third explanation is based on sample selection and the complex interactions between CVD and related factors.
Although the literature has clearly demonstrated that shorter LTL is associated with CVD in general, there are multiple discrepancies between studies depending on the specific parameter tested. For example, shorter leukocyte telomeres have been associated with hypertension, 5 but several other studies have found associations with other clinical manifestations related to CVD but not with hypertension. [8] [9] [10] These discrepancies might be related to differences in the study population, including age and sex distribution, as well as other factors associated with telomere length, such as smoking and obesity. A strength of the current study is that it is representative of the U.S. elderly population, so there is no bias toward specific subsets of individuals that might favor finding specific associations, but independent larger studies are needed to clarify these discrepancies.
Regarding associations with aging risk factors, shorter telomeres were found in men than in women, as expected, 33 but not a decrease of telomere length with age. This lack of association has previously been reported in some populations enriched in older subjects. 28, 29 The association between shorter telomeres and smoking and obesity has been reported in some studies, 18 but it is not significant in others, 9, 46 including this report. Many factors could account for these differences, among them the age of the population studied. For instance, the association between telomere shortening and insulin resistance and inflammation was reported to be absent in menopausal women, 19 which underscores a possible hormonal influence on LTL and indicates that these associations might not be found when studying older groups of individuals.
There is the potential for bias because the subset of the 1999 NLTCS used in this sample is less disabled (37%) than the sample from which it was selected. The 1999 NLTCS community interview respondents, consisting of ''screened in'' disabled patients and nondisabled ''healthy supplements'' (see Material and Methods), contained approximately 60% disabled individuals. In addition, those aged 90 and older and those who with life-threatening conditions were excluded from LTL analysis because of the potential risk of blood drawing in these subjects, leading to a sampling bias toward less-disabled people in this LTL analysis.
In the current study, as in all but one 47 published study of health correlates of peripheral blood telomere length, telomere length was measured only in unfractionated peripheral blood. However, peripheral blood is a complex mixture of cell types, and it is possible that one or more cell subsets are responsible for the strength of association with health-related parameters. This might be particularly true for associations between telomere length and age, because cell subsets (especially naive and memory T cells) are known to change with age. 48, 49 However, this explanation is unlikely in the current study, because age was not a significant covariate with telomere length, and the health conditions and stratifiers that were associated with telomere length (cancer, CVD, disability, and diabetes mellitus) are not known to be associated with any consistent change in proportions of peripheral blood cell subsets. Nevertheless, in this study, as in others, study of telomere length within cell subsets would be a useful future direction.
In conclusion, a novel association was found between LTL and disability, which supports the role of LTL as a biomarker of overall well-being, as others have suggested. 30 It has been reported that physical activity in leisure time is associated with longer telomeres. 22 The prevalence of chronic diseases that can lead to reduced activity could not explain shorter telomeres in sedentary subjects. Similarly, longer leukocyte telomeres have been associated with diets high in vitamin D. 50 These findings support the notion that a healthier lifestyle might delay telomere shortening and thus the effects of aging. Follow-up studies with independent populations are needed to confirm the role of LTL as a biomarker of overall well-being of older adults.
